Merck Stalls at Early-2024 Pivot, Struggles to Clear $120 Resistance
Merck shares stalled at the early-2024 pivot breakdown level and failed to clear resistance near the $120 zone. The stock’s 10-day buy-to-open call/put volume ratio of 5.09 ranks in the 83rd percentile while implied volatility sits in the 10th percentile.
1. Technical Resistance at $120 and 2024 Pivot
Merck shares stalled at the early-2024 pivot breakdown level and failed to breach resistance near the $120 zone, signaling weakened momentum and potential downside risk if the level holds.
2. Elevated Call Open Interest
Call open interest concentrates at the $125 strike, with the 10-day buy-to-open call/put volume ratio at 5.09, positioning in the 83rd percentile of its annual range and highlighting bullish option positioning.
3. Low Implied Volatility and Put Strategy
The Schaeffer’s Volatility Index sits in the 10th percentile, reflecting subdued implied volatility, while an April put with a 9.0 leverage ratio stands to double on a 10.1% share price decline, offering a defined downside hedge.